Latest filings (excl ownership)
15-12G
Securities registration termination
6 Apr 04
8-K
Other events
22 Mar 04
DEFA14A
Additional proxy soliciting materials
22 Mar 04
10-K
2003 FY
Annual report
12 Mar 04
DEFM14A
Proxy related to merger
1 Mar 04
DEFA14A
Additional proxy soliciting materials
24 Feb 04
DEFA14A
Additional proxy soliciting materials
20 Feb 04
PREM14A
Preliminary proxy related to merger
27 Jan 04
DEFA14A
Additional proxy soliciting materials
23 Jan 04
8-K
TheraSense Announces Fourth Quarter and Full-Year 2003 Financial Results
22 Jan 04
DEFA14A
Additional proxy soliciting materials
22 Jan 04
DEFA14A
Additional proxy soliciting materials
21 Jan 04
DEFA14A
Additional proxy soliciting materials
20 Jan 04
DFAN14A
Additional proxy materials by non-management
20 Jan 04
DEFA14A
Additional proxy soliciting materials
14 Jan 04
DEFA14A
Additional proxy soliciting materials
14 Jan 04
DEFA14A
Additional proxy soliciting materials
14 Jan 04
DEFA14A
Additional proxy soliciting materials
14 Jan 04
8-K
Other events
13 Jan 04
8-K
Abbott Laboratories to Acquire Therasense
13 Jan 04
DEFA14A
Additional proxy soliciting materials
13 Jan 04
DFAN14A
Additional proxy materials by non-management
13 Jan 04
10-Q
2003 Q3
Quarterly report
13 Nov 03
8-K
Regulation FD Disclosure
22 Oct 03
10-Q
2003 Q2
Quarterly report
14 Aug 03
8-K
Financial statements and exhibits
24 Jul 03
10-Q
2003 Q1
Quarterly report
15 May 03
8-K
TheraSense Announces First Quarter Financial Results
23 Apr 03
ARS
2002 FY
Annual report to shareholders
7 Apr 03
10-K
2002 FY
Annual report
27 Mar 03
DEF 14A
Definitive proxy
27 Mar 03
8-A12G
Registration of securities
11 Mar 03
8-K
Other events
26 Feb 03
10-Q
2002 Q3
Quarterly report
13 Nov 02
10-Q
2002 Q2
Quarterly report
14 Aug 02
10-Q
2002 Q1
Quarterly report
15 May 02
ARS
2001 FY
Annual report to shareholders
25 Mar 02
10-K405
2001 FY
Annual report (delinquent filer disclosure)
20 Mar 02
DEF 14A
Definitive proxy
20 Mar 02
S-8
Registration of securities for employees
29 Nov 01
Latest ownership filings
No filings